V-Bio Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundVIVES PartnersEQT Life SciencesSambrinvestWallonie EntreprendreEQT
Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.
AgTechBiotechFoodTechGent, BE
Benjamin Laga(Co-founder & CEO)inJonas Aper(Co-founder & Director of Breeding)in
Co-investorsAgri Investment FundInnovation IndustriesKorysEstari GroupVIBPMV+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









